Clinical Trial Update: The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Smetinib Hydrosulfate Capsule for Neurofibromatosis type 1 is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• Smetinib Hydrosulfate Capsule (smetinib hydrosulfate)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Neurofibromatosis 1 | Phase 2 | Status: NOT_YET_RECRUITING